Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction
- PMID: 10378825
- DOI: 10.1177/000331979905000607
Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction
Abstract
Basic fibroblast growth factor (bFGF) has been shown by some to promote angiogenesis and myocardial salvage in experimentally induced acute myocardial infarction. Although these findings have spurred much clinical interest, they are not universally observed, and the true efficacy of bFGF remains unclear. The authors used a rabbit model of acute myocardial infarction to further elucidate the effects of bFGF on acutely infarcted myocardium containing few collaterals. Myocardial infarction was evoked by ligation of the left coronary artery. Prior to ligation, either 100 microg of bFGF (bFGF group; n = 15) or physiological saline (control group; n = 22) was injected into the myocardium supplied by the ligated artery. With use of nonradioactive colored microspheres, regional blood flow (Qm) was measured before, immediately after, and 4 weeks after coronary artery ligation. Infarct and border zone sizes were measured in cross-sectional slices of the resected hearts, and the amount of viable myocardium (myocardium score) and the extent of fibrosis were histologically determined in each area. Four weeks after ligation, Qm values in the infarcted area did not significantly differ between the bFGF and control groups (0.54 +/- 0.36 vs 0.48 +/- 0.30 mL/min/g); in the border zone, Qm tended to be higher in the bFGF group (3.39 +/- 2.68 vs 1.47 +/- 0.80 mL/min/g), but the difference was not significant; finally in the noninfarcted area, Qm was significantly (p < 0.05) higher in the bFGF group (6.06 +/- 3.85 vs 2.09 +/- 0.82 mL/min/g). There was no significant difference in the amount of viable myocardium or the extent of fibrosis in the infarcted areas of the two groups. In the border zone, however, the amount of viable myocardium was significantly (p < 0.005) larger in the bFGF group (61.8 +/- 8.5% vs 35.8 +/- 20.3% of the visual field). Likewise, as graded on a scale from 0 to 5, the extent of fibrosis was significantly (p < 0.005) less in the bFGF group (2.1 +/- 0.5 vs 3.3 +/- 0.8). In conclusion, injection of bFGF into acutely infarcted myocardium increased blood flow to the noninfarcted area and salvaged the myocardium in the border zone.
Similar articles
-
Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs.Angiology. 1998 May;49(5):381-90. doi: 10.1177/000331979804900507. Angiology. 1998. PMID: 9591530
-
Basic fibroblast growth factor caused no change in collateral flow or infarct size of acutely-infarcted myocardium in rats.Tohoku J Exp Med. 2000 Jun;191(2):101-11. doi: 10.1620/tjem.191.101. Tohoku J Exp Med. 2000. PMID: 10946919
-
Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor.Ann Thorac Surg. 2000 Apr;69(4):1155-61. doi: 10.1016/s0003-4975(99)01557-x. Ann Thorac Surg. 2000. PMID: 10800811
-
Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness.J Artif Organs. 2004;7(2):58-61. doi: 10.1007/s10047-004-0252-1. J Artif Organs. 2004. PMID: 15309671 Review.
-
The "border zone" in evolving myocardial infarction: controversy or confusion?Am J Cardiol. 1981 Jun;47(6):1321-34. doi: 10.1016/0002-9149(81)90266-6. Am J Cardiol. 1981. PMID: 7015815 Review.
Cited by
-
Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications.Int J Nanomedicine. 2013;8:3641-62. doi: 10.2147/IJN.S43945. Epub 2013 Sep 25. Int J Nanomedicine. 2013. PMID: 24106425 Free PMC article. Review.
-
Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells.J Biomed Mater Res A. 2012 May;100(5):1356-67. doi: 10.1002/jbm.a.34075. Epub 2012 Feb 28. J Biomed Mater Res A. 2012. PMID: 22374788 Free PMC article.
-
Lysine: Is it worth more?Cytotechnology. 2001 Jul;36(1-3):3-32. doi: 10.1023/A:1014097121364. Cytotechnology. 2001. PMID: 19003311 Free PMC article.
-
Angiomyogenesis for myocardial repair.Antioxid Redox Signal. 2009 Aug;11(8):1929-44. doi: 10.1089/ars.2009.2471. Antioxid Redox Signal. 2009. PMID: 19361254 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical